Stock price crashing because the company is a scam is an entirely different thing.
These guys have done an amazing job, and I hope things work out for them.
Kind of curious that Aperture would show a significant interest, if they or anyone at HGEN had any idea of the progress "Chemo Research" was making. Were they totally blind-sided, or is there a solid basis for Aperture's interest?